ClinicalTrials.govpublic full text
Rivaroxaban Sotorasib Interaction Study
drug drug interaction study, lung cancer, non small cell lung cancer, nsclc, sotorasib, lumykras, lumakras, rivaroxaban, xarelto, doac, enzyme inhibitors, molecular mechanisms of pharmacological action
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 802006
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.